Medacta Group SA
SIX:MOVE

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
SIX:MOVE
Watchlist
Price: 111.2 CHF
Market Cap: 2.2B CHF
Have any thoughts about
Medacta Group SA?
Write Note

Medacta Group SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medacta Group SA
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Medacta Group SA
SIX:MOVE
Cost of Revenue
-€162.9m
CAGR 3-Years
-23%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Metall Zug AG
SIX:METN
Cost of Revenue
-CHf314.8m
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
-8%
Sonova Holding AG
SIX:SOON
Cost of Revenue
-CHf1B
CAGR 3-Years
-8%
CAGR 5-Years
-4%
CAGR 10-Years
-5%
Straumann Holding AG
SIX:STMN
Cost of Revenue
-CHf623.4m
CAGR 3-Years
-17%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Medmix Ltd
SIX:MEDX
Cost of Revenue
-CHf328.9m
CAGR 3-Years
-13%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Medacta Group SA
Glance View

Market Cap
2.2B CHF
Industry
Health Care

Medacta Group SA engages in the development, manufacture, and distribution of orthopedic and neurosurgical medical devices. The company is headquartered in Castel San Pietro, Ticino and currently employs 1,341 full-time employees. The company went IPO on 2019-04-04. The firm develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The firm designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.

MOVE Intrinsic Value
120.28 CHF
Undervaluation 8%
Intrinsic Value
Price

See Also

What is Medacta Group SA's Cost of Revenue?
Cost of Revenue
-162.9m EUR

Based on the financial report for Dec 31, 2023, Medacta Group SA's Cost of Revenue amounts to -162.9m EUR.

What is Medacta Group SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-19%

Over the last year, the Cost of Revenue growth was -24%. The average annual Cost of Revenue growth rates for Medacta Group SA have been -23% over the past three years , -19% over the past five years .

Back to Top